A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: A North American Brain Tumor Consortium (NABTC01-05)

PURPOSE: This phase II study was designed to determine the overall survival time of adults with supratentorial glioblastoma treated with the immune modulator, polyinosinic-polycytidylic acid stabilized with polylysine and carboxymethylcellulose (poly-ICLC), in combination with and following radiatio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Neurooncol
Main Authors: Butowski, Nicholas, Chang, Susan M., Junck, Larry, DeAngelis, Lisa M., Abrey, Lauren, Fink, Karen, Cloughesy, Tim, Lamborn, Kathleen R., Salazar, Andres M., Prados, Michael D.
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4779120/
https://ncbi.nlm.nih.gov/pubmed/18797818
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-008-9693-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados